Closing Figures Unveiled: GeneDx Holdings Corp (WGS) Drop -1.66, Closes at 31.94

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

GeneDx Holdings Corp (NASDAQ: WGS) closed the day trading at $31.94 down -1.66% from the previous closing price of $32.48. In other words, the price has decreased by -$1.66 from its previous closing price. On the day, 0.28 million shares were traded. WGS stock price reached its highest trading level at $32.73 during the session, while it also had its lowest trading level at $31.3.

Ratios:

For a better understanding of WGS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.22 and its Current Ratio is at 2.38. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.58.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Equal Weight rating and assigned the stock a target price of $34.

On July 10, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $43.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 19 ’24 when OPKO HEALTH, INC. sold 50,000 shares for $34.49 per share. The transaction valued at 1,724,520 led to the insider holds 2,646,972 shares of the business.

OPKO HEALTH, INC. sold 50,000 shares of WGS for $1,714,850 on Aug 16 ’24. The 10% Owner now owns 2,696,972 shares after completing the transaction at $34.30 per share. On Aug 15 ’24, another insider, OPKO HEALTH, INC., who serves as the 10% Owner of the company, sold 39,824 shares for $33.08 each. As a result, the insider received 1,317,505 and left with 2,746,972 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WGS now has a Market Capitalization of 860332672 and an Enterprise Value of 870433536. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.53 while its Price-to-Book (P/B) ratio in mrq is 4.43. Its current Enterprise Value per Revenue stands at 3.572 whereas that against EBITDA is -13.221.

Stock Price History:

Over the past 52 weeks, WGS has reached a high of $37.45, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 1.30%, while the 200-Day Moving Average is calculated to be 112.11%.

Shares Statistics:

Over the past 3-months, WGS traded about 421.80K shares per day on average, while over the past 10 days, WGS traded about 343360 shares per day. A total of 25.98M shares are outstanding, with a floating share count of 18.58M. Insiders hold about 31.03% of the company’s shares, while institutions hold 58.61% stake in the company. Shares short for WGS as of 1723680000 were 2048269 with a Short Ratio of 4.86, compared to 1721001600 on 1616328. Therefore, it implies a Short% of Shares Outstanding of 2048269 and a Short% of Float of 20.69.

Most Popular